Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.

Saved in:
Bibliographic Details
Title: Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.
Authors: Mkhize NN; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Yssel AEJ; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Kaldine H; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., van Dorsten RT; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; South African Medical Research Council Antiviral Gene Therapy Research Unit, School of Pathology, Faculty of Health Sciences University of the Witwatersrand, Johannesburg, South Africa., Woodward Davis AS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Beaume N; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Matten D; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Lambson B; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Modise T; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Kgagudi P; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., York T; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Westfall DH; Department of Microbiology, University of Washington, Seattle, Washington, United States of America., Giorgi EE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Korber B; Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America., Anthony C; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Mapengo RE; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Bekker V; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa., Domin E; Department of Surgery, Duke University, Durham, North Carolina, United States of America., Eaton A; Department of Surgery, Duke University, Durham, North Carolina, United States of America., Deng W; Department of Microbiology, University of Washington, Seattle, Washington, United States of America., DeCamp A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Gwashu-Nyangiwe A; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Thebus R; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Ndabambi N; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Mielke D; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Department of Surgery, Duke University, Durham, North Carolina, United States of America., Mgodi N; University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, Harare, Zimbabwe., Karuna S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Edupuganti S; Division of Infectious Diseases, Department of Medicine, Emory University, Decatur, Georgia, United States of America., Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America., Cohen MS; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North-Carolina, United States of America., Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Mullins JI; Department of Microbiology, University of Washington, Seattle, Washington, United States of America., Montefiori D; Department of Surgery, Duke University, Durham, North Carolina, United States of America., Moore PL; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa., Williamson C; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.; National Health Laboratory Service, Cape Town, South Africa., Morris L; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
Source: PLoS pathogens [PLoS Pathog] 2023 Jun 29; Vol. 19 (6), pp. e1011469. Date of Electronic Publication: 2023 Jun 29 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37384759
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mkhize+NN%22">Mkhize NN</searchLink>; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Yssel+AEJ%22">Yssel AEJ</searchLink>; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Kaldine+H%22">Kaldine H</searchLink>; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22van+Dorsten+RT%22">van Dorsten RT</searchLink>; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; South African Medical Research Council Antiviral Gene Therapy Research Unit, School of Pathology, Faculty of Health Sciences University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Woodward+Davis+AS%22">Woodward Davis AS</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Beaume+N%22">Beaume N</searchLink>; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Matten+D%22">Matten D</searchLink>; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Lambson+B%22">Lambson B</searchLink>; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Modise+T%22">Modise T</searchLink>; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Kgagudi+P%22">Kgagudi P</searchLink>; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22York+T%22">York T</searchLink>; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Westfall+DH%22">Westfall DH</searchLink>; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Giorgi+EE%22">Giorgi EE</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Korber+B%22">Korber B</searchLink>; Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.<br /><searchLink fieldCode="AU" term="%22Anthony+C%22">Anthony C</searchLink>; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Mapengo+RE%22">Mapengo RE</searchLink>; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Bekker+V%22">Bekker V</searchLink>; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Domin+E%22">Domin E</searchLink>; Department of Surgery, Duke University, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Eaton+A%22">Eaton A</searchLink>; Department of Surgery, Duke University, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Deng+W%22">Deng W</searchLink>; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22DeCamp+A%22">DeCamp A</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Huang+Y%22">Huang Y</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Gilbert+PB%22">Gilbert PB</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Gwashu-Nyangiwe+A%22">Gwashu-Nyangiwe A</searchLink>; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Thebus+R%22">Thebus R</searchLink>; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Ndabambi+N%22">Ndabambi N</searchLink>; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Mielke+D%22">Mielke D</searchLink>; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Department of Surgery, Duke University, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Mgodi+N%22">Mgodi N</searchLink>; University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, Harare, Zimbabwe.<br /><searchLink fieldCode="AU" term="%22Karuna+S%22">Karuna S</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Edupuganti+S%22">Edupuganti S</searchLink>; Division of Infectious Diseases, Department of Medicine, Emory University, Decatur, Georgia, United States of America.<br /><searchLink fieldCode="AU" term="%22Seaman+MS%22">Seaman MS</searchLink>; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Corey+L%22">Corey L</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Cohen+MS%22">Cohen MS</searchLink>; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North-Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Hural+J%22">Hural J</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22McElrath+MJ%22">McElrath MJ</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Mullins+JI%22">Mullins JI</searchLink>; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Montefiori+D%22">Montefiori D</searchLink>; Department of Surgery, Duke University, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Moore+PL%22">Moore PL</searchLink>; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.<br /><searchLink fieldCode="AU" term="%22Williamson+C%22">Williamson C</searchLink>; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.; National Health Laboratory Service, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Morris+L%22">Morris L</searchLink>; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2023 Jun 29; Vol. 19 (6), pp. e1011469. <i>Date of Electronic Publication: </i>2023 Jun 29 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37384759
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.ppat.1011469
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1011469
    Titles:
      – TitleFull: Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mkhize NN
      – PersonEntity:
          Name:
            NameFull: Yssel AEJ
      – PersonEntity:
          Name:
            NameFull: Kaldine H
      – PersonEntity:
          Name:
            NameFull: van Dorsten RT
      – PersonEntity:
          Name:
            NameFull: Woodward Davis AS
      – PersonEntity:
          Name:
            NameFull: Beaume N
      – PersonEntity:
          Name:
            NameFull: Matten D
      – PersonEntity:
          Name:
            NameFull: Lambson B
      – PersonEntity:
          Name:
            NameFull: Modise T
      – PersonEntity:
          Name:
            NameFull: Kgagudi P
      – PersonEntity:
          Name:
            NameFull: York T
      – PersonEntity:
          Name:
            NameFull: Westfall DH
      – PersonEntity:
          Name:
            NameFull: Giorgi EE
      – PersonEntity:
          Name:
            NameFull: Korber B
      – PersonEntity:
          Name:
            NameFull: Anthony C
      – PersonEntity:
          Name:
            NameFull: Mapengo RE
      – PersonEntity:
          Name:
            NameFull: Bekker V
      – PersonEntity:
          Name:
            NameFull: Domin E
      – PersonEntity:
          Name:
            NameFull: Eaton A
      – PersonEntity:
          Name:
            NameFull: Deng W
      – PersonEntity:
          Name:
            NameFull: DeCamp A
      – PersonEntity:
          Name:
            NameFull: Huang Y
      – PersonEntity:
          Name:
            NameFull: Gilbert PB
      – PersonEntity:
          Name:
            NameFull: Gwashu-Nyangiwe A
      – PersonEntity:
          Name:
            NameFull: Thebus R
      – PersonEntity:
          Name:
            NameFull: Ndabambi N
      – PersonEntity:
          Name:
            NameFull: Mielke D
      – PersonEntity:
          Name:
            NameFull: Mgodi N
      – PersonEntity:
          Name:
            NameFull: Karuna S
      – PersonEntity:
          Name:
            NameFull: Edupuganti S
      – PersonEntity:
          Name:
            NameFull: Seaman MS
      – PersonEntity:
          Name:
            NameFull: Corey L
      – PersonEntity:
          Name:
            NameFull: Cohen MS
      – PersonEntity:
          Name:
            NameFull: Hural J
      – PersonEntity:
          Name:
            NameFull: McElrath MJ
      – PersonEntity:
          Name:
            NameFull: Mullins JI
      – PersonEntity:
          Name:
            NameFull: Montefiori D
      – PersonEntity:
          Name:
            NameFull: Moore PL
      – PersonEntity:
          Name:
            NameFull: Williamson C
      – PersonEntity:
          Name:
            NameFull: Morris L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 06
              Text: 2023 Jun 29
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1553-7374
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: PLoS pathogens
              Type: main
ResultId 1